NCT04531449View on ClinicalTrials.gov

EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity)

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Point of Care Monitoring
Trial Locations (1)

PO6 3LY

Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth

All Listed Sponsors
lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT04531449 - EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity) | Biotech Hunter | Biotech Hunter